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Abstract Monocyte-derived mononuclear phagocytes, par-
ticularly macrophages, are crucial to maintain gastrointestinal
homeostasis in the steady state but are also important for pro-
tection against certain pathogens. However, when uncon-
trolled, they can promote immunopathology. Broadly two
subsets of macrophages can be considered to perform the vast
array of functions to complete these complex tasks: resident
macrophages that dominate in the healthy gut and
inflammation-elicited (inflammatory) macrophages that de-
rive from circulating monocytes infiltrating inflamed tissue.
Here, we discuss the features of resident and inflammatory
intestinal macrophages, complexities in identifying and defin-
ing these populations and the mechanisms involved in their
differentiation. In particular, focus will be placed on describ-
ing their unique ontogeny as well as local gastrointestinal
signals that instruct specialisation of resident macrophages in
healthy tissue. We then explore the very different roles of
inflammatory macrophages and describe new data suggesting
that they may be educated not only by the gut microenviron-
ment but also by signals they receive during development in
the bone marrow. Given the high degree of plasticity of gut
macrophages and their multifaceted roles in both healthy and
inflamed tissue, understanding the mechanisms controlling
their differentiation could inform development of improved
therapies for inflammatory diseases such as inflammatory
bowel disease (IBD).
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Introduction
The mammalian intestine is a complex environment for the
immune system. On one hand, it must maintain tolerance to a
vast array of antigens derived from food and the dense, but
largely harmless, commensal microbiota. On the other, it must
be ever ready to respond to potentially life-threatening patho-
gens that aim to colonise via the oral route. Failure to achieve
this knife-edge balance between tolerance and responsiveness
can lead to mortality or life-limiting morbidity, as occurs in
inflammatory bowel disease (IBD).
For ongoing homeostasis to be achieved in the gut, inter-
related highly specialised structural and cellular strategies
have, thus, evolved to support this immunologic balancing
act. All the time allowing the tissue to perform its primary
physiologic function—absorption of nutrients, water and elec-
trolytes. These structures include a mucus layer that creates a
physical barrier to keep bacteria away from the epithelium, a
single-cell thick epithelial layer and a specialised immune
network enriched in the epithelial layer and lamina propria.
Resulting from their phagocytic capacity, functional plas-
ticity and capability to integrate and interpret diverse food-
derived, commensal-derived, pathogen-derived and host-
derived signals in their environment, gut-resident macro-
phages are well established as a keystone immune population
in barrier homeostasis in health. Moreover, following initia-
tion of an inflammatory response, inflammation-elicited
(inflammatory) macrophages (derived from circulating blood
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monocytes called into the affected tissue) in tandem with their
resident partners play crucial roles in control of infection.
Thus, in the face of the myriad challenges that the intestine
will face over a lifetime, the dynamic regulation of the intes-
tinal macrophage pool is at the centre of long-term health.
Macrophage biology is a field that has seen explosive
growth in recent years, particularly in the gut. A large number
of studies, including our work, have begun to establish how the
ontogeny and differentiation of these cells is tailored by, and to,
the gut environment. In this article, we will discuss these find-
ings and particularly explore the uniquemechanisms governing
resident and recruited inflammatory gut macrophage function.
Location and functions of resident macrophages
in the healthy gut
The largest population of resident macrophages in the body is
present in the steady-state intestine [42, 56]. They are found
along the entire length of the intestine, from the proximal
small intestine to the distal large intestine, and are enriched
in the lamina propria (LP) close to the epithelial layer (see
Fig. 1) [42]. There is also a morphologically distinct popula-
tion present in the smooth muscle layers [21]. Along the
length of the gut, the number of macrophages varies, with
the highest density found in the colon of both humans and
rodents [16, 70].
As in most tissues, a key role of macrophages in the gut is to
perform housekeeping functions such as tissue remodelling and
removal of senescent or dying cells [14, 70, 78]. In line with
this function, they have high expression of scavenger receptors,
including CD36, that are able to support apoptotic cell uptake
[95]. They are also able to produce soluble factors that can help
to support epithelial barrier integrity such as the lipid mediator
prostaglandin E2 (PGE2) [25]. Additionally, macrophages lo-
cated in the muscularis and serosa are important in interacting
with nerves to support peristalsis, ensuring ongoing movement
of ingested material along the intestine [69].
However, alongside these homeostatic functions, macro-
phages in the gut are also important immune sentinels and ef-
fector populations. The positioning of LP macrophages in close
apposition to the epithelial layer means that they are able to
rapidly uptake and respond to any material breaching this bar-
rier [42]. These residentmacrophages are highly phagocytic and
have bactericidal properties [96]. They can also produce
chemokines to recruit effector cells from the blood into the

















Fig. 1 Development and
functions of resident intestinal
macrophages. In the healthy gut,
Ly6Chi monocytes are constantly
recruited from the blood into the
gut to replenish the resident
macrophage pool. Ly6Chi
monocytes transit through a series
of phenotypically defined stages
to eventually become mature
CX3CR1hiMHCIIhiLy6Clow
macrophages in the lamina
propria and muscularis. These
macrophages are hyporesponsive
to bacterial ligands, constitutively
produce IL-10 and have multiple
crucial functions in gut homeo-
stasis including Treg expansion,
epithelial maintenance, luminal
sampling and bacterial killing
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macrophage populations in the body, although gut macrophages
can respond to bacteria, they do not induce classic pro-
inflammatory responses [4, 96]. This is a critical feature to pre-
vent aberrant inflammation towards the high commensal bacte-
rial load [118]. For example, ingestion of bacteria does not lead
to enhanced respiratory burst activity [80], and ligation of toll-
like receptors (TLRs) or nucleotide-binding oligomerisation do-
main (NOD)-like receptors (NLRs) does not result in increased
TNF-α or IL-6 production [34, 96]. Despite this hyporespon-
sive phenotype towards bacteria, intestinal macrophages are not
completely unresponsive in their cytokine-producing capacity,
and they constitutively produce the anti-inflammatory cytokine
IL-10 and low levels of TNF-α [4]. Although this production of
TNF-α may at first seem counterintuitive (due to its inflamma-
tory capacity), TNF-α can impact enterocyte growth [61] as
well as modulating production of matrix metalloproteinases
from intestinal mesechymal cells [75], actions which are sug-
gested to allow gut macrophages to support the maintenance of
barrier homeostasis [3].
An important component of the gut immune system that is
critical in establishing tolerance towards the high burden of
food and commensal antigens is the forkhead box protein 3
(Foxp3)+ T regulatory cell (Treg) network [65]. Since gut
macrophages are able to uptake orally acquired antigens and
also express high levels of major histocompatibility complex
class II (MHCII) [4, 65], it is not surprising that they are
suggested to play a key role in supporting development of this
network. Of note, Hadis et al. demonstrated that following
their priming in the lymph node, antigen-specific Foxp3+
Tregs that had trafficked to the LP were maintained at this site
by macrophages [32]. A similar role for macrophages in con-
tributing to the tissue-resident Treg pool has also been sug-
gested in the lung [98].
It is possible that gut macrophages may play roles in
supporting maintenance of other T cell subsets in the gut. In
particular, macrophages can produce IL-1β following TLR
stimulation, and this has been suggested to support Th17 cell
development in the healthy gut [93]. Along these lines, re-
cruited macrophages have also been shown to support gener-
ation of commensal-specific Th17 cells [74]. Although
gastrointestinal-resident Th17 cells are key mediators of bar-
rier defence [113], dysregulated Th17 responses are a driver of
colitogenic pathology, and in settings of gastrointestinal in-
flammation, macrophages have been shown to support ampli-
fication of Th17 responses [58]. Further studies will be re-
quired to establish whether macrophage education of gastro-
intestinal T cell populations requires cognate MHCII-T cell
receptor interactions or whether the cytokine milieu
established by macrophages is the major factor. Moreover,
the influence of macrophages on other gastrointestinal-
resident lymphocyte populations during steady state requires
further assessment, especially in the light of reports detailing
macrophage-innate lymphoid cell (ILC) interactions which
are key to support gastrointestinal immune homeostasis and
reinforce barrier integrity [63, 68, 88].
Another way in which gut macrophages may be able to
support development of the gut T cell network in an indirect
manner is by transfer of soluble antigen from the lumen to gut
dendritic cells (DCs) [65]. These DCs then drain to the mes-
enteric lymph nodes to prime T cell responses [85]. It is still
not entirely clear how LP macrophages acquire these luminal
antigens, but one possibility is that they can extend
transepithelial dendrites across the epithelium [10, 72].
However, this idea remains controversial with original reports
disagreeing on which parts of the small intestine these
transepithelial dendrites were present in and the necessity for
TLR signalling, and subsequent studies unable to identify
them [10, 51, 72].
An issue that has confounded functional studies of gut
macrophages has been the complexities of identifying this
population using flow cytometry [3, 8, 41]. Initially, this prob-
lem largely arose due to the assumption that CD11c and
MHCII were markers of gut DCs. In the gut, LP macrophages
express high levels of CD11c as well as MHCII and thus in
many studies were assumed to be DCs [6, 10]. Unlike macro-
phages, DC constantly drain from tissue to lymph nodes
where their major role is to prime naïve T cells [85]. More
recently, the fractalkine receptor CX3CR1 has been used to
distinguish gut macrophages from gut DC [6, 85, 111].
Notably, resident gut macrophages express high levels of
CX3CR1; however, some subsets of gut DC also express this
marker (albeit at an intermediate level), which may be the
basis of more recent contradictory findings regarding DC
and macrophage function [3, 8, 41].
One problem with using high expression of CX3CR1 as a
marker of gut macrophages is that this can currently only be
established using CX3CR1-GFP transgenic mice and not by
antibody staining [46]. A more useful strategy for identifying
gut macrophages by multicolour flow cytometry (that can be
used in non CX3CR1-GFP expressing animals) came from
large-scale genomic datasets alongside more targeted studies
[2, 4, 23, 104]. Together, these publications have identified
that CD64 (FcγRI), F4/80 and MHCII used in combination
with Ly6C and lineage exclusion markers (e.g. for lympho-
cytes and granulocytes) can reliably define these cells. CD11c
expression was found to be of particular relevance to distin-
guish LP macrophages (CD11chi) from those in the serosa and
muscularis (CD11clow) [6]. When isolated by fluorescence-
activated cell sorting (FACS), these cells exhibit characteristic
macrophage morphology and cannot be found draining to the
mesenteric lymph nodes [2, 41]. Moreover, their development
is critically dependent on colony stimulating factor 1 receptor
(CSF1R) (also known as macrophage colony-stimulating fac-
tor receptor (MCSFR)) [82, 83] but independent of the DC
growth factor FMS-like tyrosine kinase 3 ligand (FLT3L)
[104]. Altogether, these findings suggest that CD64 and F4/
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80 are bona fidemarkers of gut-resident macrophages and will
support researchers in specifically determining gut macro-
phage functions in future studies.
The unusual ontogeny of resident gut macrophages
When the mononuclear phagocyte system (MPS) was first
described just over 50 years ago, it was proposed that tissue
macrophages were the terminal differentiation stage of blood
monocytes after recruitment into tissue [110]. However, in
more recent years, a number of studies have been published
that demonstrate that the majority of tissue macrophages are
able to exist independently of blood monocyte precursors [33,
38, 39]. Frequently these derive from foetal liver precursors
although some, including the microglia of the central nervous
system (CNS), come from the yolk sac [24, 38, 39, 116].
These cells seed tissues prenatally and then are maintained
by local proliferation. Resident macrophages include those
of the lung alveoli [116], the Kuppfer cells of the liver [87]
and epidermal Langerhans cells [39].
The adult intestinal macrophage pool is a major exception
to this rule (along with the dermis [103] and more controver-
sially the heart [18, 66]) fitting the original MPS model, re-
quiring constant replenishment from blood monocytes (see
Fig. 1) [2, 4, 6, 119]. Blood monocytes are a heterogeneous
circulating population in both humans and mice that originate
in the bone marrow (BM). In mice, there is a subset that
expresses high levels of Ly6C and CCR2 termed Bclassical^
monocytes (the equivalent of human CD14hi monocytes [43])
that are the precursors to the adult intestinal macrophages [2,
4, 6, 119]. Although at birth, there are embryonically derived
macrophages present in the gut, around the time of weaning
these are replaced by cells derived from an influx of CCR2-
dependent Ly6Chi monocytes [2].
A number of studies investigating macrophage differ-
entiation in the healthy gut have been instrumental in
defining the phenotypic and transcriptional profile of clas-
sical (Ly6Chi) blood monocytes transitioning into mature
gut macrophages. Initially using an adoptive transfer ap-
proach in healthy gut, it was shown that Ly6Chi mono-
cytes were able to enter into the colon and mature into
CD64+F4/80hiCX3CR1hiMHCII+ macrophages [4]. This
developmental process involves a series of identifiable
intermediaries in which Ly6C expression is lost while
expression of F4/80, CX3CR1, CD163 and CD206 are
gained. Due to the visual appearance of this transition
moving from Ly6Chi to MHCIIhi or CX3CR1hi on a flow
cytometry plot, this has been referred to as the monocyte
to macrophage Bwaterfall^ [2, 104]. Differentiation takes
approximately 5 days and results in a cell that has in-
creased phagocytic capacity and constitutive IL-10 pro-
duction and is anergic to TLR stimulation. This rapid
differentiation is in line with earlier reports of an
approximately 3–5-week half-life for gut-resident macro-
phages [45]. Although the precise mechanisms governing dif-
ferentiation cannot be easily established in humans, resident gut
macrophages deriving from blood monocytes is implied by a
similar waterfall of CD14hi (marker characteristic of classical
monocytes [43]) to CD14lowCD209hiCD163hi cells [4].
The complex commensal flora is a distinguishing feature of
the intestine, and there is a current consensus that it is this
feature that is important in regulating the continuous replen-
ishment of resident gut macrophages from blood monocytes
[2, 3, 118]. Of note, there is a first accumulation of colonic
macrophages between 2 and 3 weeks of age in mice that is
concurrent with increased commensal colonisation [2].
Corroborating the importance of the microbiome in this pro-
cess, at 3 weeks of age, there were fewer mature macrophages
in germ-free mice than conventionally housed controls.
Moreover, many of these macrophages did not express
MHCII further implicating the microbiome in typical differ-
entiation of macrophages as well as recruitment [4, 119].
It is worth noting, however, that this was not the first study
to investigate colonic macrophage abundancy in germ-free
animals, and these studies have reached opposing conclusions
[71, 79, 108]. Animals from different sources are now well
known to have very different commensal composition [11, 44,
107]. One hypothesis for these differences between studies is
that there are unique factors in the gut other than the
microbiome that can affect macrophage replacement from
blood monocytes but that specific bacterial species present
in certain mouse colonies can enhance or decrease the turn-
over rate.
Taken together, the studies to date strongly suggest that in
both mice and humans, and in stark contrast to other tissues,
resident gut macrophages are continuously replenished from
circulating blood monocytes. Whether this information can be
used to design strategies to specifically target gut macro-
phages remains to be explored but suggests that they may be
impacted by systemic drug administration in a way that mac-
rophages maintained locally in tissue would not.
Instruction of resident gut macrophage function
The main cues present in the gut environment that are respon-
sible for monocyte to resident macrophage differentiation are
still poorly defined. However, it is likely that there are specific
signals or combinations of signals in the gut that induce char-
acteristics not observed at other mucosal sites such as the skin
and lung [55, 86, 103, 109].
There are a number of important growth factors involved in
the establishment of the MPS, notably, FLT3L, CSF1 (MCSF)
and CSF2 (granulocyte macrophage colony-stimulating fac-
tor). Although FLT3L and CSF2 may have impacts on gut
macrophage function [68], they appear to be dispensable for
their development [26, 104]. This is in stark contrast to lung
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macrophages for which CSF2 signalling is extremely impor-
tant [30, 101]. Two ligands have been identified for CSF1R:
CSF1 itself and IL-34 [112]. It seems most likely that devel-
opment and maintenance of macrophages in the gut are CSF1
dependent as there is a marked reduction of macrophages in
mice that have a mutation in the gene that encodes CSF1
(Csf1op/op) or following administration of anti-CSF1R anti-
body [69, 82].
One particularly unusual phenotype of resident gut macro-
phages is their acquisition of high levels of CX3CR1 expres-
sion. In the majority of tissues, CX3CR1 is downregulated on
macrophages suggesting that there is a factor in the gut re-
sponsible for its continued expression. A recent study has
suggested that TGF-β, which is established to induce
CX3CR1 expression in the brain [9], is also a dominant signal
for CX3CR1 expression by gut macrophages [84]. This is in
line with the identification of Runx3 as a characteristic tran-
scription factor of gut macrophages that is regulated by
TGF-β in T cells [52, 53, 55]. In addition, it is possible that
the interaction of CX3CR1 with CX3CL1 (fractalkine) may
be important itself in instructing gut macrophage function. For
example, it has been suggested that CX3CR1-CX3CL1 inter-
actions are critical for optimal production of IL-10 by macro-
phages [32].
IL-10 signalling is one pathway that has been shown to be
crucial for instructing macrophage function in the gastrointes-
tinal (GI) mucosa [94, 117]. Not only do macrophages make
IL-10, but IL-10 signals to the macrophage are vital for the
appropriate education of intestinal macrophage populations,
providing a key cue that safeguards their hyporesponsive phe-
notype (discussed below). It has long been known that in the
absence of IL-10, severe gastrointestinal inflammation results
[54]; what is now clear is that IL-10 receptor signalling on
macrophages, but not the production of IL-10 itself, is key
in restraining this inflammation [94, 117]. When unable to
respond to IL-10, gut macrophages produce increased levels
of inflammatory cytokines in response to bacterial stimulation
[102, 108] and drive development of colitis [40]. More recent-
ly, specific deletion of IL-10Rα on CX3CR1-expressing gut
macrophages was shown to lead to the development of a spon-
taneous, and severe, ulcerative colitis-like GI inflammation
[117]. Part of this IL-10 conditioning of macrophage function
has been reported to include limiting levels of NOS2, PGE2,
IL-23 [117], inflammasome components and pro-IL-1β [19,
31, 58]. Thus, IL-10 signals have emerged as a vital restraint
against overt macrophage activation. Interestingly, this path-
way has also been implicated in early onset IBD, as similar
functional alterations to those seen in animal models have
been observed in patients with IL-10R mutations [94].
As mentioned, another key feature of gut macrophages is
their apparent hyporesponsiveness to TLR-mediated activa-
tion. Intriguingly, gut-resident macrophages both in humans
and mice express a full repertoire of TLR receptors, so it is
thought that it is downstream mediators that are responsible
for the hyporesponsiveness [4, 97]. Of note, molecules includ-
ing MyD88, TRAF-6, TRIF and CD14 are downregulated in
mature macrophages [96, 97, 119]. Additionally, there may be
alternative pathways that impair TLR responsiveness, for ex-
ample, through increased expression of IRAK-M and IκΒNS
[37, 97, 119].
An emerging mediator of gut macrophage function is neu-
roendocrine signals, controlling macrophage survival and
phenotype within the highly innervated gastrointestinal muco-
sa. Neuronal-macrophage interactions are bidirectional with
macrophages in the muscularis capable of controlling peristal-
tic activity. Bone morphogenetic protein 2 (BMP2), produced
by macrophages, acts on enteric neurons to control smooth
muscle contractions and thus, peristalsis [69]. In return, neu-
roendocrine signals to macrophages support maintenance of
macrophage populations within specific gastrointestinal
niches. Bogunovic and colleagues demonstrated that enteric
neurons ensure maintenance of macrophages specifically
within the muscularis layer of the gastrointestinal tract through
production of CSF1 [69] (as discussed a key growth factor in
gut macrophage development). This neuroendocrine control
of macrophage survival was downstream of commensal bac-
teria colonisation as microbial-derived signals promoted en-
teric neuron expression of CSF1. Additional macrophage
niche specialisation by neuroendocrine pathways can also be
driven by norepinephrine signals from sympathetic neurons.
Muscarlis macrophages express β2 adrenergic receptors that,
upon binding of norepinephrine released from local active
neurons, promote acquisition of a tissue-protective pro-
gramme in muscularis-resident macrophages during infection
[21].
Intriguingly, and in line with microbial activation of CSF1
production from enteric neurones [69], it has also been report-
ed that the microbiota controls glial cell homeostasis in the
intestine [47]. These supporting cells provide key mainte-
nance and protection for neurons further highlighting the com-
plex integration of microbial, endocrine and immune signals
in controlling GI immune homeostasis and inflammation. The
very recent focus on neuroendocrine signals in control of im-
mune cell function within the gut [64] will likely yield further
insights into tissue training of macrophage function by these
signals.
In addition to the signals described, there are many other
factors expressed in the gut environment that may play impor-
tant roles on macrophages but as yet have been poorly ex-
plored. These factors include thymic stromal lymphopoietin
(TSLP), the mucus layer itself that has been shown to modify
DC function [92] and retinoic acid. Retinoic acid is particu-
larly intriguing as it is known to have profound effects on DC
in the gut and in tandem with TGF-β support induction of
Treg [12, 100]. The impact of RA on macrophages has yet
to be precisely elucidated.
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Inflammatory gut macrophages in experimental settings
of classical inflammation
Infiltration of classical (Ly6Chi) monocytes that differentiate
rapidly into effector cells is a common feature following intes-
tinal damage and infection ofmice [4, 25, 104, 119] (see Fig. 2).
Perhaps the best-studied murine models of this are colitis in-
duced by administration of dextran sodium sulphate (DSS) and
T cell transfer colitis [4, 104, 119]. In both of these settings,
there is a characteristic reversal in the composition of the mac-
rophage compartment. In particular, CX3CR1hi-resident gut
macrophages that dominate in the healthy gut are outcompeted
by inflammation-elicited CX3CR1int mononuclear phagocytes
(MNPs) that are the progeny of rapidly infiltrating Ly6Chi
monocytes [4, 119]. Precise definitions of the functions of this
MNP pool are complex, and the cells within this pool are on a
differentiation spectrum that likely includes populations with
more macrophage-like or DC-like functions [119]. For the rest
of this review, focus will be placed on the macrophage-like
features of these cells that are present in inflammation that for
clarity will be referred to as inflammatory macrophages
(although the reader should note, and as will be discussed,
that their functional and differentiation potential as well as
morphology is very different to resident gut macro-
phages). These cells have a strong pro-inflammatory sig-
nature characterised by the production of factors including
TNF-α, IL-1β, IL-6 and inducible nitric oxide synthase
(iNOS). Of note, despite their presence in this pro-
inflammatory milieu, the resident CX3CR1hi macrophages
continue to maintain the largely anti-inflammatory char-
acteristics they exhibit in health [4, 104, 114, 119]. Not
surprisingly, given their pro-inflammatory features, there
is strong evidence for a pathologic role for the CX3CR1int
macrophages in these murine models of colitis. For exam-
ple, in Ccr2−/− mice (which have a paucity of monocyte-
derived cells in circulation and tissues due to a failure in
classical monocyte release from the bone marrow [89]), or
animals depleted of CCR2-expressing cells [119], there is
an amelioration of DSS-driven colitic inflammation.
One intriguing feature of the Ly6Chi monocyte differentia-
tion pathway to inflammatory macrophages during colitis is the



















Fig. 2 Macrophages during gut
inflammation. Following epithelial
damage or pathogen invasion,
classical monocyte-derived effector
cells are elicited and enter the now
inflamed GI tract. The functions of
these populations are poorly de-
fined but likely highly specialised to
the precise challenge and may in-
clude DC-like activities. Many dif-
ferentiate into macrophages that are
crucial for pathogen control but can
also lead to pathology as a result of
their potential to produce inflam-
matory cytokines such as TNF-α.
During T. gondii infection, these
cells also take on the capacity to
suppress neutrophil activation via
release of PGE2. Of note, during
T. gondii infection, instruction of
macrophage function begins in the
bone marrow resulting in mono-
cytes entering the tissue in a primed
state characterised by their low ex-
pression of CX3CR1 and high ex-
pression of MHCII. Although
monocytes no longer differentiate
to resident macrophages
(CX3CR1hi lamina propria and
muscularis macrophages) during
inflammation, those present prior to
barrier breach remain in the tissue
and continue to exhibit anti-
inflammatory features
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differentiation to resident CX3CR1hi macrophages [4, 104,
119]. Indeed, it has been proposed that this arrest in the differ-
entiation pathwaymay underlie the ongoing capacity of inflam-
matory macrophages to respond to TLR stimulation in DSS
colitis. The precise mechanisms that result in such changes
are currently unknown but are likely due to signals being altered
in the local microenvironment that are critical for educating
monocytes to become resident anti-inflammatorymacrophages.
Despite inflammatory macrophages playing immuno
pathogenic roles during acute colitic-like inflammation, in
certain gastrointestinal infections, they are crucial for patho-
gen protection [17, 25]. Following oral inoculation with the
highly type 1 polarising intracellular protozoan parasite
Toxoplasma gondii, there is dramatic infiltration of Ly6Chi
monocytes into the inflamed small intestine [17, 25]. Once
again, the importance of monocytes in this setting can be
revealed by the fact that CCR2-deficient mice or those defi-
cient in its ligand CCL2 fail to control the parasite [17, 25],
and this can be restored by monocyte transfer [17].
Although, this parasite control was initially attributed to the
capacity of recently recruited macrophages to produce pro-
inflammatory cytokines such as TNF-α and iNOS, their func-
tion has since been revealed to be more complex [25]. Our
studies demonstrated that in CCR2-deficient animals infected
with T. gondii, neutrophils became hyperactivated in the lam-
ina propria of the gut where they produced dramatically in-
creased levels of tissue damaging factors including TNF-α
and reactive oxygen species (ROS) [25]. This was associated
with increased severity of gastrointestinal pathology that was
independent of increases in parasite load. Immunofluorescent
imaging revealed that Ly6Chi inflammatory macrophages
localised closely with neutrophils in the inflamed gut suggest-
ing that one explanation for their enhanced activity might be
direct suppressive actions of Ly6Chi macrophages. Supporting
this idea, we found that treatment of neutrophils with factors
released from Ly6Chi macrophages isolated from T. gondii-
infected guts limited the neutrophils’ capacity to produce
pro-inflammatory factors in response to TLR ligands and for-
myl peptides. Further experiments revealed that this effect was
entirely dependent on the release of the lipid mediator PGE2,
which is highly expressed by inflammatory macrophages dur-
ing T. gondii infection [1, 25] (see Fig. 2). This lipid mediator
can have complex and opposing roles over the course of an
inflammatory response as it can favour inflammatory cell re-
cruitment [48] but is also a potent suppressor of human neu-
trophil activation [115].
Following its initial invasion of the gut, T. gondii in-
fection eventually disseminates systemically and inflam-
matory macrophages infiltrate lymphoid tissues including
the spleen [25]. However, the neutrophil-suppressive ac-
tivity was only evident in macrophages isolated from the
gut. Studies using germ-free (GF) mice revealed that this
was critically dependent on commensal-derived ligands.
The precise bacteria involved in instructing macrophage
function during inflammation are likely very different to
those resident macrophages are exposed to in health.
Notably, in the context of gut infection, there is tremen-
dous outgrowth of potentially pathogenic commensal
populations, specifically γ-proteobacteria such as
Esche r i c h i a co l i [ 3 5 , 67 ] . Ou t g r ow th o f γ -
proteobacteria has also been reported in patients with
IBD [15, 59]. Indeed, in vitro treatment of circulating
Ly6Chi monocytes from the blood of T. gondii-infected
animals with a lysate from a commensal form of E. coli
led to rapid PGE2 production. Of course, in vivo, there
may be additional gut-specific signals responsible for
initiating PGE2 release. For example, stimulated epitheli-
al cells can produce and activate IL-1β [99], a strong
d r i ve r o f PGE2 f rom mac rophages [76 ] , and
commensal-derived dietary ligands such as short chain
fatty acids (SCFAs) can also augment PGE2 production
[13]. It is interesting to speculate that in certain individ-
uals or at defined time points during infection, alterations
in the composition of commensal species may be able to
favour acquisition of regulatory features by infiltrating
monocytes.
Another mechanism by which inflammatory macrophages
may act to suppress immune cells during inflammation is via
actions on T cells. This could be achieved by modifying L-
arginine metabolism, as nitric oxide (NO) limits T cell prolif-
eration [5]. Inflammatory macrophages in the GI tract during
acute infection and inflammation have been shown to be pos-
itive for this immune mediator. In the spleen, during Listeria
monocytogenes infection, iNOS+ macrophages suppress
antigen-specific T cell responses [90]. Given the prevalence
of iNOS+ macrophages in the GI tract during inflammation,
these data imply that these cells may well be capable of sup-
pressing effector T cell responses in the GI mucosa. In line
with this, a CX3CR1+CD11c+CD11b+ MNP in the GI tract
has been shown to be capable of limiting CD4+ T cell prolif-
eration [50]. This required cell-cell contact highlighting anoth-
er mechanism that could be employed by macrophages to
curtail gastrointestinal T cell responses.
Macrophages in human gut inflammation
Mechanistic understanding of macrophages in human gut in-
flammation is much more limited than in animal models. One
thing that is clear is that CD14hi MNP accumulate in the in-
flamed gut in settings such as IBD [49], likely in response to
elevated levels of the chemokines CCL2 and CCL4 [95].
Indeed, by radiolabelling of autologous blood monocytes, it
was demonstrated that the CD14hi cells arise from these cir-
culating precursors [27]. These cells are the human equivalent
of the Ly6Chi populations in mice that become dominant dur-
ing induced colitis and oral T. gondii infection [4, 17, 25, 104,
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119]. As with recruited macrophages in the mouse, the CD14hi
cells in the inflamed human intestine produce high levels of
TNF-α, IL-1β and IL-6 [81] and have ongoing responsive-
ness to microbe-derived factors [49, 105].
In addition to cytokine release, it has also been reported
that macrophages in the inflamed mucosa have increased ex-
pression of CD40 that may support local interactions with
pathology-driving effector T cells [7], again mirroring data
from murine models [119]. Given the currently sparse data
on human intestinal macrophage function, but their high rele-
vance to disease pathology, this will no doubt be an area for
tremendous future scientific study. The already strong similar-
ities between patient samples and murine models suggest that
integration of these two investigative strategies may be key to
rapidly progressing our knowledge of this area.
Long-range instruction of inflammatory gut macrophage
function during infection
At steady state, much research focus has been placed on the
cues present in the gut environment that locally instruct resi-
dent gut macrophage differentiation. Based on this model,
during gut inflammation, factors at the affected tissue site to
which infection-elicited macrophages are exposed have been
of primary interest. However, a number of recent findings,
including those from our group, suggest that a more holistic
approach to understanding macrophage differentiation during
inflammation needs to be employed.
It is well established that when stressed, tissues such as the
gut can send signals to the bone marrow (BM) niche and
blood to improve supply of required circulating immune pop-
ulations [28, 89]. We found that during gut infection, these
long-range signals can also instruct for altered functional po-
tential. As early as 4 days after oral infection with T. gondii,
Ly6Chi monocytes developing in the BM niche acquired a
characteristic CX3CR1lowMHCIIhiSca-1hi phenotype, which
was also observed in inflammatory gut macrophages [1] sug-
gesting that instruction of eventual macrophage differentiation
may be beginning in the BM. Most importantly, when highly
pure BM Ly6Chi monocytes were isolated by FACS from
naïve and T. gondii-infected animals and exposed to commen-
sal signals they ultimately would experience in the inflamed
gut, they already had enhanced capacity to produce PGE2
prior to BM efflux. As discussed already, we have established
PGE2 as a critical recruited gut macrophage-derived factor
regulating neutrophil-mediated immunopathology during oral
T. gondii infection [25]. Thus, during gut infection, functional
priming of inflammatory macrophages can begin in the BM.
Although PGE2 production was highlighted, the Ly6C
hi
monocytes had profound transcriptional changes and also
had enhanced capacity to produce anti-inflammatory IL-10
in response to bacterial ligands. These transcriptional changes
were at least initiated in the direct proliferative precursor to
monocytes, the common monocyte progenitor (cMoP) [36],
but earlier progenitors such as the MDP were not investigated
due to issues of identification in infection [1].
The precise mechanisms that the gut can use to communi-
cate to the BM niche are not understood. During T. gondii
infection, we identified a whole organism signalling loop in
which a specific subset of gut DC (Batf3+) released the cyto-
kine IL-12 in the serum that was detected by a subset of ma-
ture natural killer (NK) cells present in the BM. These NK
cells produced IFN-γ locally in the BM in response to the IL-
12 signal, which was critical in generating the high PGE2-
producing CX3CR1lowMHCIIhiSca-1hi monocytes. Although
IFN-γ was a dominant signal, whether additional signals in
the BM environment are also altered following T. gondii in-
fection and whether these have specific functional effects on
developing monocytes and eventually their gut macrophage
progeny remain unknown. One possibility is food-derived li-
gands such as short-chain fatty acids (SCFAs), as these have
previously been shown to modify DC function prior to exit
from the BM in an asthma model [106].
Intriguingly, during T. gondii infection, our data suggested
that perturbations to monocyte-macrophage differentiation ca-
pacity might be initiated systemically, as there were dramatic
increases in circulating Ly6Chi monocytes with a concurrent
loss of Ly6Clow patrolling monocytes (which are suggested to
derive from the Ly6Chi population [116]). This bears striking
similarity to the proposed block in differentiation of mono-
cytes to resident gut macrophages in colitis [4, 119]. The cy-
tokine IFN-γ was implicated in this process [1], but further
work will be needed to confirm whether this is due to an arrest
in normal differentiation pathways (rather than, for example,
increased BM output of Ly6Chi monocytes) and whether these
Ly6Chi monocytes are also unable to differentiate into resident
macrophages upon entry into the gut.
Resident and inflammatory macrophages in resolution
of inflammation
Once the infection, or other inflammation-driving factor, has
been cleared or becomes tolerated in the gut, there must be a
resolution phase to restore homeostasis. If this does not hap-
pen, then chronic inflammation may develop.
As occurs during inflammation, this resolution phase is
also associated with striking alterations to gut macrophage
subsets. One example of this is that following resolution of
DSS colitis in mice, the augmented CX3CR1int MNP subset
returns to baseline levels [119]. Precise reasons for the loss of
the CX3CR1int subset are not known, but apoptosis and up-
take by resident macrophages seem probable [22]. An alter-
native possibility, based on the idea that CX3CR1int cells are
blocked in their differentiation to resident gut macrophages
during inflammation, is that due to alterations in the cytokine
milieu, this limitation is removed. As a result, many of the
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CX3CR1int cells would Bdisappear^ from the gut by differen-
tiating into resident gut macrophages.
Whatever the case, it seems that gut monocytes/macrophages
are important in gut repair and resolution of inflammation. In
particular, there is a delay in DSS colitis resolution in animals
that lack TGF-β signalling on monocytes/macrophages (CD68-
dnTGFβRII) [78], while deletion of MyD88 signalling in mye-
loid cells limits gut healing [62].
Although not well studied specifically in the gut, one set of
factors that are important in restoration of homeostasis in all
tissues are pro-resolving lipid mediators [91]. These factors, as
well as limiting influx of additional inflammatory cells, can
promote the uptake of apoptotic cells by macrophages [20,
29]. Types of lipid mediators include lipoxins, resolvins and
protectins that can be produced bymultiple cell types including
macrophages [91]. One factor that has been demonstrated to
favour production of lipoxins is prostaglandins, in particular
PGE2. For example, in resolving inflammatory exudates, it
has been suggested that PGE2 and PGD2 can stimulate produc-
tion of a functional enzyme for lipoxin in neutrophils [57].
Based on our studies in T. gondii infection, this raises the in-
triguing possibility that Ly6Chi monocytes/macrophages not
only limit neutrophil activation but also deviate their function
towards a lipoxin-producing pro-resolution state. Relating to
this, macrophages may also be able to regulate wound healing
directly by interacting with epithelial progenitor cells during
colonic wound healing [77]. Again, lipid mediators may play
a role in this process as COX-2 expression, a critical factor in
PGE2 production, has been linked to protection of progenitor
populations at other tissue sites during inflammation [60].
As well as repairing the barrier, another feature of return to
homeostasis is the restoration of the adaptive immune com-
partment, which can become dramatically perturbed during an
inflammatory response [73]. At this time, it is unclear how the
mononuclear phagocytes of the gut may act together to sup-
port this return, but given their suggested role in expanding
Tregs at steady state, it is likely that gut-resident macrophages
are important to this process.
With the recent advances in technologies for the generation of
transgenic murine systems, novel tools for the temporal knockout
of specific genes in defined macrophage/monocyte subsets are
likely to become increasingly available. This will allow candidate
factors identified as being important to resolution to be depleted
during this phase of the inflammatory response without impairing
initiation of disease. Already, the tamoxifen-inducible
Cx3CR1creER mouse that knocks out factors in CX3CR1hi-resi-
dent gutmacrophages holdsmuch promise for this purpose [116].
Concluding remarks
Utilising novel transgenic animals alongside cutting-edge cyto-
metric and genomic approaches, recent years have seen an explo-
sion in our understanding of macrophage biology in general and
more specifically in the gut. In particular, the field is beginning to
better define the diverse functions that these cells play in tissue
homeostasis and how they can be manipulated in disease states.
With the advent of single-cell RNA sequencing, it will
become more straightforward to define functionally distinct
macrophage subsets within complex and potentially inflamed
tissue environments. One aspect of macrophage biology that
has been largely overlooked in recent years is precise
localisation within the tissue. For example, in the gastrointes-
tinal tract, there are diverse structural components to the tis-
sue, e.g. muscle, nerves, blood vessels and epithelium. How
macrophage function might be tailored to each of these niches
is only just beginning to be understood.
Another area in the functional diversity arena is to further
understand the differential roles of resident macrophages versus
inflammatory macrophages in disease states. It is clear that resi-
dent macrophages are often maintained in the inflammatory en-
vironment but are not acquiring classical activation markers.
Whether these cells play a role during the active inflammatory
event or in restoring homeostasis post challenge is extremely
unclear. This is critical to understand as it would help elucidate
specific macrophage factors that can be manipulated at defined
time points in the inflammation resolution cycle to alter outcome.
Whatever the future of macrophage research holds, given the
importance of intestinal macrophages to the maintenance of ho-
meostasis and disease progression, better understanding the de-
velopment and functions of this cell type will no doubt yield
novel strategies that can inform development of therapies to
improve patient outcome in inflammatory diseases such as IBD.
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